Abstract
OBJECTIVE:
To compare the neurodevelopmental outcome of premature infants treated with recombinant human erythropoietin with that of control infants.
STUDY DESIGN:
A total of 20 treated infants and 20 control infants who had completed randomized, double-blind, placebo-controlled studies of recombinant human erythropoietin as treatment for anemia of prematurity were followed for growth and developmental outcome in an intensive care nursery follow-up program. Infants were assessed by standard developmental tests.
RESULTS:
No differences were found between groups for neurologic outcome, cognitive outcome, or growth patterns. All infants treated with recombinant human erythropoietin were neurologically normal. The rate of cognitive deficits was similar in the two groups.
CONCLUSION: In this small sample we did not see differences in neurodevelopmental outcome between infants treated with recombinant human erythropoietin and control infants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
This work was supported in part by National Institutes of Health GrantM01RR01271; Pediatric Clinical Research Center, University ofCalifornia, San Francisco. The controlled trials of rHuEPO treatmentwere also supported in part by the R. W. Johnson PharmaceuticalResearch Institute (Raritan, NJ).
Rights and permissions
About this article
Cite this article
Newton, N., Leonard, C., Piecuch, R. et al. Neurodevelopmental Outcome of Prematurely Born Children Treated With Recombinant Human Erythropoietin in Infancy. J Perinatol 19, 403–406 (1999). https://doi.org/10.1038/sj.jp.7200244
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7200244
This article is cited by
-
Neuroimaging in former preterm children who received erythropoiesis stimulating agents
Pediatric Research (2017)
-
Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report
Italian Journal of Pediatrics (2015)
-
A Meta-analysis of the Protective Effect of Recombinant Human Erythropoietin (rhEPO) for Neurodevelopment in Preterm Infants
Cell Biochemistry and Biophysics (2015)
-
Outcomes of extremely low birth weight infants given early high-dose erythropoietin
Journal of Perinatology (2013)
-
Neuroprotective effects of erythropoietin in preterm infants
Nature Reviews Neurology (2010)